Rhythm Pharmaceuticals is transitioning from a development stage to a commercial rare disease leader, leveraging its IMCIVREE ...

Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo ...

A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic ...

Beginning July 1, millions of Americans on Medicare will have access to GLP-1 weight-loss drugs for just $50 a month. Under ...

Subsidiary Sands China Ltd. repeats on the Dow Jones Best-in-Class World, Asia Pacific indices. LAS VEGAS, NV / ACCESS ...

Discover why weight loss is complex, influenced by hormones and the brain, and explore the latest treatments for obesity. Read more at straitstimes.com. Read more at straitstimes.com.

A low-calorie diet program may facilitate significant weight loss among older patients with persistent atrial fibrillation, ...

The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...

Experimental Pancreatic Cancer Drug Shows Survival Benefit in Major Trial A long-awaited breakthrough may finally be emerging ...

Important progress across four clinical-stage programs demonstrating depth and breadth of obesity pipeline Initiated five ...

The latest to join the trend is Jiangnan University in Jiangsu province. In early April, the university issued a student ...

Weight-loss jabs can reduce the risk of cancer and stop it from becoming incurable, research has suggested. A study has found ...